Share this article and save a life!
MRI just became a molecular microscope for your entire body.
Philips dropped something game-changing at ISMRM 2026 yesterday: the Titanion MR with 150 mT/m gradient performance.
Think about what this means 🔬
We’re no longer just looking at anatomy. We’re measuring microstructures. Cell density. Tissue characteristics invisible to standard MRI.
This isn’t incremental improvement, it’s a paradigm shift.
Traditional MRI: Shows you what’s there
Titanion MR: Tells you what it’s made of
The implications for oncology alone are staggering.
Imagine detecting cancer not by size, but by cellular behavior. Tracking treatment response through molecular changes before tumors shrink. Personalizing therapy based on tissue microstructure.
But here’s what excites me most:
Quantitative biomarkers across the entire body. No more subjective reads. No more “looks like” or “appears to be.” Just objective, measurable data.
AI-powered software processes this ultra-high gradient data into actionable insights. Every scan becomes a comprehensive molecular assessment.
For community hospitals and FQHCs, this technology eventually trickling down means:
• Earlier disease detection
• More precise treatment planning
• Reduced need for invasive biopsies
• Better outcomes for underserved populations
Yes, it’s expensive now. Yes, adoption will take time.
But remember when 3T MRI was only in academic centers? Now it’s standard of care.
The same will happen here.
We’re witnessing radiology transform from photography to biochemistry. From seeing structure to understanding function.
This isn’t just better imaging. It’s a new language for understanding disease.
The question isn’t if this changes everything. It’s how fast we can get it to the patients who need it most.
♻️ Repost if molecular imaging should be accessible to all patients
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
